Oyster-Derived Tyr-Ala (YA) Peptide Prevents Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Suppressing Inflammatory, Apoptotic, Ferroptotic, and Pyroptotic Signals

Oyster hydrolysate ameliorates ethanol diet–induced alcoholic fatty liver by regulating lipid metabolism in rats

(2021) Jae‐Hyuk Byun et al.   INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY

M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis

(2021) Li Bai et al.   Cell Death & Disease

Niujiaodihuang Detoxify Decoction inhibits ferroptosis by enhancing glutathione synthesis in acute liver failure models

(2021) Yichun Ji et al.   JOURNAL OF ETHNOPHARMACOLOGY

Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review

(2020) Anton Gillessen et al.   ADVANCES IN THERAPY

Activation of the NF-κB and MAPK Signaling Pathways Contributes to the Inflammatory Responses, but Not Cell Injury, in IPEC-1 Cells Challenged with Hydrogen Peroxide

(2020) Kan Xiao et al.   Oxidative Medicine and Cellular Longevity

Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells

(2020) Sen Yang et al.   Frontiers in Immunology

Cross talk between intracellular pathogens and cell death

(2020) Benjamin Demarco et al.   IMMUNOLOGICAL REVIEWS

The emerging role of ferroptosis in non-cancer liver diseases: hype or increasing hope?

(2020) Lihong Mao et al.   Cell Death & Disease

Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study

(2020) Xing-Ran Zhai et al.   BMC GASTROENTEROLOGY

Dipeptide YA is Responsible for the Positive Effect of Oyster Hydrolysates on Alcohol Metabolism in Single Ethanol Binge Rodent Models

(2020) Adrian S. Siregar et al.   Marine Drugs

Involvement of TREK-1 Channel in Cell Viability of H9c2 Rat Cardiomyoblasts Affected by Bupivacaine and Lipid Emulsion

(2019) Yang et al.   Cells

Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress

(2019) Yao Wang et al.   Molecular Medicine Reports

Gasdermin D-mediated hepatocyte pyroptosis expands inflammatory responses that aggravate acute liver failure by upregulating monocyte chemotactic protein 1/CC chemokine receptor-2 to recruit macrophages

(2019) Hong Li et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases

(2018) Mohammad Hassan Baig et al.   BIOMEDICINE & PHARMACOTHERAPY

GDF‑15 prevents LPS and D‑galactosamine‑induced inflammation and acute liver injury in mice

(2018) Min Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Ferroptosis-Induced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis

(2018) Young-Sun Lee et al.   MOLECULAR CANCER RESEARCH

Quantification of Multifunctional Dipeptide YA from Oyster Hydrolysate for Quality Control and Efficacy Evaluation

(2018) Cheng-Liang Xie et al.   Biomed Research International

Kaempferol protects mice from d-GalN/LPS-induced acute liver failure by regulating the ER stress-Grp78-CHOP signaling pathway

(2018) Huijuan Wang et al.   BIOMEDICINE & PHARMACOTHERAPY

Genipin protects d -galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the necroptosis-mediated inflammasome signaling

(2017) Min-Jong Seo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The Protective Effect of Cordycepin on D-Galactosamine/Lipopolysaccharide-Induced Acute Liver Injury

(2017) Jin Li et al.   MEDIATORS OF INFLAMMATION

Glycyrrhetinic acid attenuates lipopolysaccharide-induced fulminant hepatic failure in d -galactosamine-sensitized mice by up-regulating expression of interleukin-1 receptor-associated kinase-M

(2017) Xinru Yin et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Ferroptosis: process and function

(2016) Y Xie et al.   CELL DEATH AND DIFFERENTIATION

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

(2016) Hans-Theo Schon et al.   Frontiers in Pharmacology

Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling

(2015) Kyle S. McCommis et al.   Cell Metabolism

ER stress induces NLRP3 inflammasome activation and hepatocyte death

(2015) C Lebeaupin et al.   Cell Death & Disease

Nature and mechanisms of hepatocyte apoptosis induced by d-galactosamine/lipopolysaccharide challenge in mice

(2014) YI-HANG WU et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Angiotensin I-Converting Enzyme Inhibitor Derived from Cross-Linked Oyster Protein

(2014) Cheng-Liang Xie et al.   Biomed Research International

Food-Derived Bioactive Peptides on Inflammation and Oxidative Stress

(2014) Subhadeep Chakrabarti et al.   Biomed Research International

Acute Liver Failure

(2013) William Bernal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibition of Glycogen Synthase Kinase 3β Ameliorates D-GalN/LPS-Induced Liver Injury by Reducing Endoplasmic Reticulum Stress-Triggered Apoptosis

(2012) Liyan Chen et al.   PLoS One

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

(2008) W. Ray Kim et al.   HEPATOLOGY

From endoplasmic-reticulum stress to the inflammatory response

(2008) Kezhong Zhang et al.   NATURE

Assessment of drug–drug interaction for silymarin

(2008) Johannes Doehmer et al.   TOXICOLOGY IN VITRO

Antileukoproteinase protects against hepatic inflammation, but not apoptosis in the response of D-galactosamine-sensitized mice to lipopolysaccharide

(2007) C Eipel et al.   BRITISH JOURNAL OF PHARMACOLOGY